001     841289
005     20240625095113.0
024 7 _ |a 10.1021/acs.jmedchem.7b01388
|2 doi
024 7 _ |a 0022-2623
|2 ISSN
024 7 _ |a 0095-9065
|2 ISSN
024 7 _ |a 1520-4804
|2 ISSN
024 7 _ |a 1943-2992
|2 ISSN
024 7 _ |a 2128/17604
|2 Handle
024 7 _ |a pmid:29077404
|2 pmid
024 7 _ |a WOS:000425063400051
|2 WOS
024 7 _ |a altmetric:28766460
|2 altmetric
037 _ _ |a FZJ-2017-08380
082 _ _ |a 540
100 1 _ |a Ortega, Jose Antonio
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Pharmacophore Hybridization To Discover Novel Topoisomerase II Poisons with Promising Antiproliferative Activity
260 _ _ |a Washington, DC
|c 2018
|b ACS
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1520840248_25960
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a We used a pharmacophore hybridization strategy to combine key structural elements of merbarone and etoposide and generated new type II topoisomerase (topoII) poisons. This first set of hybrid topoII poisons shows promising antiproliferative activity on human cancer cells, endorsing their further exploration for anticancer drug discovery.
536 _ _ |a 574 - Theory, modelling and simulation (POF3-574)
|0 G:(DE-HGF)POF3-574
|c POF3-574
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Riccardi, Laura
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Minniti, Elirosa
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Borgogno, Marco
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Arencibia, Jose M.
|0 0000-0003-3227-931X
|b 4
700 1 _ |a Greco, Maria L.
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Minarini, Anna
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Sissi, Claudia
|0 0000-0002-9713-1415
|b 7
|e Corresponding author
700 1 _ |a De Vivo, Marco
|0 0000-0003-4022-5661
|b 8
|e Corresponding author
773 _ _ |a 10.1021/acs.jmedchem.7b01388
|g p. acs.jmedchem.7b01388
|0 PERI:(DE-600)1491411-6
|n 3
|p 1375-1379
|t Journal of medicinal chemistry
|v 61
|y 2018
|x 1520-4804
856 4 _ |y OpenAccess
|u https://juser.fz-juelich.de/record/841289/files/acs.jmedchem.7b01388.pdf
856 4 _ |y OpenAccess
|x icon
|u https://juser.fz-juelich.de/record/841289/files/acs.jmedchem.7b01388.gif?subformat=icon
856 4 _ |y OpenAccess
|x icon-1440
|u https://juser.fz-juelich.de/record/841289/files/acs.jmedchem.7b01388.jpg?subformat=icon-1440
856 4 _ |y OpenAccess
|x icon-180
|u https://juser.fz-juelich.de/record/841289/files/acs.jmedchem.7b01388.jpg?subformat=icon-180
856 4 _ |y OpenAccess
|x icon-640
|u https://juser.fz-juelich.de/record/841289/files/acs.jmedchem.7b01388.jpg?subformat=icon-640
856 4 _ |y OpenAccess
|x pdfa
|u https://juser.fz-juelich.de/record/841289/files/acs.jmedchem.7b01388.pdf?subformat=pdfa
909 C O |o oai:juser.fz-juelich.de:841289
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 8
|6 0000-0003-4022-5661
913 1 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-574
|2 G:(DE-HGF)POF3-500
|v Theory, modelling and simulation
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2018
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Free to read
|0 LIC:(DE-HGF)PublisherOA
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J MED CHEM : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J MED CHEM : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)IAS-5-20120330
|k IAS-5
|l Computational Biomedicine
|x 0
920 1 _ |0 I:(DE-Juel1)INM-9-20140121
|k INM-9
|l Computational Biomedicine
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)IAS-5-20120330
980 _ _ |a I:(DE-Juel1)INM-9-20140121
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21